Changes After Suprachoroidal Injection.

Not Applicable

• Conditions: Retina; Change; Cataract; Macular Edema; Intraocular Pressure
• Interventions: Drug: Suprachoroidal triamcinolone acetonide (SCTA) injection

• Registration Number: NCT05288192
• Lead Sponsor: Benha University

Brief Summary

Changes after suprachoroidal injection are analyzed for statistical analysis.

Detailed Description

Changes after suprachoroidal injection of triamcinolone acetonide are noted in various retinal diseases treated by this technique to address its effects over six months of follow-up.

Study Timeline

• Study Start: 2022-02-15
• Status Verified: 2022-03
• Study First Submitted: 2022-03-11
• Study First Submitted QC: 2022-03-11
• Last Update Submitted: 2022-03-11
• Study First Posted: 2022-03-21
• Last Update Posted: 2022-03-21
• Primary Completion: 2022-08-30
• Study Completion: 2022-09-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study.
• Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies.

Exclusion Criteria

• Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations.
• Choroidal neovascularization that require anti-vascular endothelial growth factors.
• Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Suprachoroidal triamcinolone injection	Suprachoroidal triamcinolone acetonide (SCTA) injection	Eyes treated with suprachoroidal injection of triamcinolone acetonide.

Primary Outcome Measures

Name	Time	Method
Changes in visual acuity	Monthly after injection till six months of follow up	Changes in best corrected visual acuity after injection
Changes in central foveal thickness	Monthly after injection till six months of follow up	Changes in central macular thickness after injection

Secondary Outcome Measures

Name	Time	Method
Changes in lens	Monthly after injection till six months of follow up	Cataract progression after injection
Changes in intraocular pressure	Monthly after injection till six months of follow up	Changes in intraocular pressure after injection

Trial Locations

Locations (1)

Benha University; 🇪🇬 Banhā, QA, Egypt